Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5387)
All Articles published online
|
Publishing Process of This Article
|
Jul 28, 2014 (publication date) through Jan 20, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tao F, Ye MF, Sun AJ, Lv JQ, Xu GG, Jing YM, Wang W. Prognostic significance of nuclear hepatoma-derived growth factor expression in gallbladder cancer. World J Gastroenterol 2014; 20(28): 9564-9569 [PMID: 25071353 DOI: 10.3748/wjg.v20.i28.9564] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i28/9564.htm |
| Number | Citing Articles |
| 1 |
Ci-Hang Bao, Kun Liu, Xin-Tong Wang, Wei Ma, Jian-Bo Wang, Cong Wang, Yi-Bin Jia, Na-Na Wang, Bing-Xu Tan, Qing-Xu Song, Yu-Feng Cheng. Prognostic Role of Hepatoma-derived Growth Factor in Solid Tumors of Eastern Asia: a Systematic Review and Meta-Analysis. Asian Pacific Journal of Cancer Prevention 2015; 16(5): 1803 doi: 10.7314/APJCP.2015.16.5.1803
|
| 2 |
Jianming Tang, Huijuan Shi, Hui Li, Tiantian Zhen, Yu Dong, Fenfen Zhang, Yang Yang, Anjia Han. The interaction of hepatoma-derived growth factor and β-catenin promotes tumorigenesis of synovial sarcoma. Tumor Biology 2016; 37(8): 10287 doi: 10.1007/s13277-016-4905-5
|
| 3 |
Feilong Yang, Nengwang Yu, Hui Wang, Cong Zhang, Zhao Zhang, Yanxiang Li, Dawei Li, Lei Yan, Hainan Liu, Zhonghua Xu, Aamir Ahmad. Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2, MMP9. PLOS ONE 2018; 13(1): e0190725 doi: 10.1371/journal.pone.0190725
|
| 4 |
Jiayan Lian, Jianming Tang, Huijuan Shi, Hui Li, Tiantian Zhen, Wenlin Xie, Fenfen Zhang, Yang Yang, Anjia Han. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer. Oncotarget 2015; 6(30): 29357 doi: 10.18632/oncotarget.4982
|
| 5 |
Kyungeun Kim, Hyoun Wook Lee, Seoung Wan Chae, Dong-Hoon Kim, In Gu Do, Hyun Joo Lee, Sung-Im Do, Kyueng-Whan Min, Jung-Soo Pyo, Jun-Ho Shin, Jin Hee Sohn. Cytokeratin 17 Expression is Associated With Poor Prognosis in Gallbladder Adenocarcinoma. Applied Immunohistochemistry & Molecular Morphology 2017; 25(5): 346 doi: 10.1097/PAI.0000000000000307
|
| 6 |
Yan Ma, Xiu Lian Xu, Hai Ge Huang, Yan Feng Li, Zhi Guo Li. LncRNA TDRG1 promotes the aggressiveness of gastric carcinoma through regulating miR-873-5p/HDGF axis. Biomedicine & Pharmacotherapy 2020; 121: 109425 doi: 10.1016/j.biopha.2019.109425
|
| 7 |
Tobias Wagner, Dina Robaa, Wolfgang Sippl, Manfred Jung. Drug Discovery in Cancer Epigenetics. 2016; : 273 doi: 10.1016/B978-0-12-802208-5.00011-4
|
| 8 |
Young Hun Kim, Won Kee Lee, Jae Yong Park, Dong Sun Kim. Prognostic value of hepatoma-derived growth factor-related protein 3 (HRP-3) methylation in non-small cell lung cancer. Genes & Genomics 2015; 37(5): 479 doi: 10.1007/s13258-015-0277-2
|
| 9 |
Eduardo E. Montalvo-Jave, Amir A. Rahnemai- Azar, Dimitrios Papaconstantinou, Mariana Espejel Deloiza, Diamantis I. Tsilimigras, Dimitrios Moris, German Eduardo Mendoza-Barrera, Sharon M. Weber, Timothy M. Pawlik. Molecular pathways and potential biomarkers in gallbladder cancer: A comprehensive review. Surgical Oncology 2019; 31: 83 doi: 10.1016/j.suronc.2019.09.006
|
| 10 |
Hirayuki Enomoto, Hideji Nakamura, Weidong Liu, Shuhei Nishiguchi. Hepatoma-Derived Growth Factor: Its Possible Involvement in the Progression of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2015; 16(6): 14086 doi: 10.3390/ijms160614086
|
| 11 |
NAP1L1 promotes tumor proliferation through HDGF/C-JUN signaling in ovarian cancer. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09356-z
|
| 12 |
Tian-Huei Chu, Shih-Tsung Huang, Sheau-Fang Yang, Chia-Jung Li, Hung-Wei Lin, Bi-Chuang Weng, Shih-Ming Yang, Shih-Chung Huang, Jian-Ching Wu, Yi-Chen Chang, Zhi-Hong Wen, Yi-Ming Arthur Chen, Wen-Jeng Wu, Mei-Lang Kung, Po-Han Tai, Deng-Chyang Wu, Ming-Hong Tai. Hepatoma-derived growth factor participates in Helicobacter Pylori-induced neutrophils recruitment, gastritis and gastric carcinogenesis. Oncogene 2019; 38(37): 6461 doi: 10.1038/s41388-019-0886-3
|
| 13 |
Hirayuki Enomoto, Hideji Nakamura, Hiroki Nishikawa, Shuhei Nishiguchi, Hiroko Iijima. Hepatoma-Derived Growth Factor: An Overview and Its Role as a Potential Therapeutic Target Molecule for Digestive Malignancies. International Journal of Molecular Sciences 2020; 21(12): 4216 doi: 10.3390/ijms21124216
|